Drug makers face another $65 billion patent cliff By: MarketWatch December 10, 2014 at 12:41 PM EST Drug makers face another $65 billion patent cliff through the end of 2019, a research firm says. Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb Pfizer